Works matching IS 10109609 AND DT 2015 AND VI 29 AND IP 4

Results: 46

ATC/DDD classification.
Published in:
2015
Publication type:
Chart/Diagram/Graph
Consultation documents.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 482
Publication type:
Article
Publications and events.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 471
Publication type:
Article
WHO endorsements.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 469
Publication type:
Article
Extensions of indications.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 469
Publication type:
Article
EMA Article 58 positive opinion.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 468
Publication type:
Article
Approved.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 463
Publication type:
Article
EMA and WHO share non-public information.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 462
Publication type:
Article
Regulators of United Kingdom and India sign agreement.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 462
Publication type:
Article
Meeting of World Pharmacopoeias held in China.
Published in:
2015
Publication type:
Proceeding
China and WHO collaborate on medicines quality.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 461
Publication type:
Article
ICH announces organizational changes.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 461
Publication type:
Article
EMA initiative to improve patient registries.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 460
Publication type:
Article
New Zealand working on new regulatory regime.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 460
Publication type:
Article
Accelerated access pathways in Europe.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 460
Publication type:
Article
Falsified product alert.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 459
Publication type:
Article
Dibotermin alfa-containing implant kit: suspended in Europe.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 458
Publication type:
Article
Apotex: Canada import ban lifted, product re-testing imposed.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 458
Publication type:
Article
Improved packaging for dementia treatments.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 458
Publication type:
Article
Safety reviews started.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 457
Publication type:
Article
HIV medicines: class warnings about lipodystrophy and lactic acidosis removed.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 457
Publication type:
Article
Entacapone: no clear evidence of cardiovascular events.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 457
Publication type:
Article
Human papillomavirus vaccines: benefits outweigh risks.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 456
Publication type:
Article
Clopidogrel: no increased risk of death.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 456
Publication type:
Article
Dimethyl fumarate and other fumarate-containing medicines: new monitoring measures.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 456
Publication type:
Article
Clozapine: severe neutropenia.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 455
Publication type:
Article
Strontium: cardiovascular risks.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 455
Publication type:
Article
Roxithromycin: pseudo--membranous colitis, cardiac effects.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 455
Publication type:
Article
Ceftriaxone: acute generalised exanthematous pustulosis.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 455
Publication type:
Article
Mycophenolate: avoid exposure in pregnancy.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 454
Publication type:
Article
Canagliflozin: decreased bone mineral density.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 454
Publication type:
Article
Magnesium oxide: hypermagnesaemia in older patients.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 454
Publication type:
Article
Iodine-containing contrast agents: hypoactive thyroid in infants.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 453
Publication type:
Article
Sodium polystyrene sulfonate: separate dosing to prevent interactions.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 453
Publication type:
Article
Aripiprazole: impulse control disorders.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 453
Publication type:
Article
Fingolimod: skin cancer.
Published in:
2015
Publication type:
Abstract
Crizotinib: heart failure.
Published in:
2015
Publication type:
Abstract
Vemurafenib: potentiation of radiation toxicity.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 452
Publication type:
Article
Daclatasvir hydrochloride and asunaprevir: interstitial pneumonia.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 452
Publication type:
Article
Antiviral combinations for hepatitis C: liver injury.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 451
Publication type:
Article
Proton pump inhibitors: subacute cutaneous lupus erythematosus.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 451
Publication type:
Article
Mirabegron: contraindicated in patients with severe hypertension.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 451
Publication type:
Article
Quality of medicines.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 445
Publication type:
Article
Pharmacopoeial standards.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 440
Publication type:
Article
Cooperation.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 435
Publication type:
Article
Proposed International Nonproprietary Names: List 114.
Published in:
WHO Drug Information, 2015, v. 29, n. 4, p. 504
Publication type:
Article